Physician profile
Mark Camilleri
NPI 1912992470
$975.39
in general payments reported to CMS, 2019-2025
12 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.37 · 2021: $53.83 · 2022: $17.23 · 2023: $258 · 2024: $289 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $382.99 | 2024-2025 | Nuzyra |
| Organogenesis INC. | $246.15 | 2023-2025 | Puraply, Nushield, Novachor |
| Orthofix Medical, INC. | $74.96 | 2023-2025 | Physio-Stim |
| Osteomed LLC | $53.83 | 2021 | |
| Integra Lifesciences Corporation | $46.72 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $44.94 | 2025 | Tenotac |
| Medtronic, INC. | $43.52 | 2025 | Inceptiv |
| Smith+Nephew, INC. | $22.70 | 2019 | |
| Polynovo North America LLC | $21.29 | 2024 | Novosorb Btm |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.23 | 2022 | |
| Stryker Corporation | $15.39 | 2024 | Viaflow, Actishield, Graftjacket |
| Fidia Pharma USA INC. | $5.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Camilleri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.